ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2026
Neuroligin-2-Dependent Adhesion Defines a Molecular Checkpoint for Inhibitory Synaptic Plasticity.
Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long-term regulation of inhibitory synaptic strength is crucial for maintaining excitation-inhibition (E/I) balance in cortical circuits. In this study, we identify neuroligin-2 (Nlgn2) as a critical mediator of inhibitory long-term potentiation (iLTP) in hippocampal CA1 pyramidal cells (PCs). Using neurolide-2, a synthetic dendrimeric peptide that selectively interferes with Nlgn2-neurexin binding, in combination with whole-cell recordings in mouse hippocampal slices, we show that this interaction is required to maintain NMDA-induced iLTP. Disruption of Nlgn2-neurexin interactions blocked gephyrin clustering during iLTP and prevented Nlgn2 recruitment to GABAergic synapses, without affecting baseline inhibitory transmission. Immunostaining revealed that NMDA-induced enlargement of synaptic Nlgn2 clusters occurred selectively in the CA1 stratum oriens and was abolished by neurolide-2. Temporally controlled peptide application revealed a brief, 10 min post-induction window during which Nlgn2-neurexin adhesion is required for iLTP consolidation, and later application had no effect. Optogenetic experiments further demonstrated that NMDA-induced iLTP at both somatostatin (SST) and parvalbumin (PV) inputs depends on Nlgn2. In a more physiological paradigm, high-frequency stimulation of excitatory inputs paired with postsynaptic CA1 PC depolarization triggered heterosynaptic iLTP selectively at SST → PC synapses, which was unaffected during induction but failed to consolidate when Nlgn2-neurexin interaction was blocked, whereas excitatory LTP and PV-mediated inhibition remained intact. These findings identify perisynaptic Nlgn2-neurexin adhesion as an activity-dependent mechanism supporting inhibitory plasticity depending on input identity and induction protocol. Disruption of this process may impair inhibitory circuit remodeling, contributing to E/I imbalance in neurodevelopmental and psychiatric disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.